Nabiha Yusuf Selected Research

Hydrocarbons

5/2015	In Vivo Suppression of Heat Shock Protein (HSP)27 and HSP70 Accelerates DMBA-Induced Skin Carcinogenesis by Inducing Antigenic Unresponsiveness to the Initiating Carcinogenic Chemical.
2/2012	Cell mediated immune responses through TLR4 prevents DMBA-induced mammary carcinogenesis in mice.
1/2008	Protective role of Toll-like receptor 4 during the initiation stage of cutaneous chemical carcinogenesis.
11/2007	Acquired and innate immunity to polyaromatic hydrocarbons.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nabiha Yusuf Research Topics

Disease

29	Neoplasms (Cancer) 02/2022 - 03/2004
13	Carcinogenesis 01/2022 - 11/2007
10	Skin Neoplasms (Skin Cancer) 02/2022 - 02/2007
8	Inflammation (Inflammations) 10/2021 - 05/2006
5	Melanoma (Melanoma, Malignant) 01/2021 - 02/2007
3	Neoplasm Metastasis (Metastasis) 06/2015 - 01/2012
3	Breast Neoplasms (Breast Cancer) 06/2015 - 01/2012
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 01/2021
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2021 - 01/2018
2	Infections 01/2018 - 08/2004
2	Contact Dermatitis (Eczema, Contact) 01/2015 - 01/2009
1	Xeroderma Pigmentosum (Kaposi's Disease) 10/2021
1	Dysplastic Nevus Syndrome (Dysplastic Nevus) 01/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2019
1	Cachexia 11/2018
1	Hyperplasia 11/2017
1	Dyslipidemias (Dyslipidemia) 09/2017
1	Basal Cell Carcinoma (Rodent Ulcer) 01/2017
1	Nevus (Nevi) 05/2016
1	Fibrosarcoma 10/2011
1	Autoimmune Diseases (Autoimmune Disease) 03/2010

Drug/Important Bio-Agent (IBA)

9	CytokinesIBA 01/2021 - 01/2009
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2004
6	Interleukin-17 (Interleukin 17)IBA 01/2021 - 01/2008
5	InterleukinsIBA 01/2021 - 11/2009
5	9,10-Dimethyl-1,2-benzanthraceneIBA 01/2021 - 01/2008
4	CarcinogensIBA 02/2022 - 11/2007
4	Toll-Like Receptors (Toll-Like Receptor)IBA 11/2017 - 01/2012
4	HydrocarbonsIBA 05/2015 - 11/2007
3	Biological ProductsIBA 01/2022 - 01/2018
3	Pharmaceutical PreparationsIBA 01/2022 - 10/2018
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 10/2018
3	Toll-Like Receptor 4IBA 10/2021 - 01/2008
3	Interleukin-12 (IL 12)IBA 01/2021 - 11/2009
3	Interleukin-10 (Interleukin 10)IBA 01/2021 - 03/2011
3	baicalinIBA 01/2019 - 11/2015
2	Interferon Type IIBA 02/2022 - 01/2014
2	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 01/2021
2	AntioxidantsIBA 01/2022 - 05/2006
2	InterferonsIBA 01/2021 - 03/2011
2	Interleukin-23 (Interleukin 23)IBA 01/2021 - 01/2018
2	Caspase 3 (Caspase-3)IBA 01/2021 - 10/2011
2	ChemokinesIBA 11/2018 - 01/2012
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 11/2017 - 11/2009
2	Calcitriol Receptors (Calcitriol Receptor)IBA 10/2017 - 01/2015
2	InflammasomesIBA 01/2017 - 07/2013
2	anthraceneIBA 05/2016 - 03/2004
2	Interleukin-17 ReceptorsIBA 01/2015 - 01/2012
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2009 - 05/2006
1	Fluorouracil (Carac)FDA LinkGeneric 01/2022
1	PhytochemicalsIBA 01/2022
1	Messenger RNA (mRNA)IBA 10/2021
1	ethyl 6- (N- (2- chloro- 4- fluorophenyl)sulfamoyl)cyclohex- 1- ene- 1- carboxylateIBA 10/2021
1	Therapeutic UsesIBA 01/2021
1	phenethyl isothiocyanate (PEITC)IBA 01/2021
1	AcrylatesIBA 05/2020
1	2-ethylhexyl acrylateIBA 05/2020
1	PyrroloiminoquinonesIBA 07/2019
1	Antineoplastic Agents (Antineoplastics)IBA 07/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	VemurafenibIBA 01/2019
1	Sulfhydryl Compounds (Thiols)IBA 10/2018
1	LigandsIBA 10/2018
1	hepsinIBA 10/2018
1	Peptides (Polypeptides)IBA 10/2018
1	DisulfidesIBA 10/2018
1	polymethacrylic acid (PMAA)IBA 10/2018
1	AminesIBA 10/2018
1	HydrogelsIBA 10/2018
1	AntibodiesIBA 01/2018
1	Dinoprostone (PGE2)FDA Link 11/2017
1	Tumor Suppressor Protein p14ARF (p14ARF)IBA 11/2017
1	CeramidesIBA 11/2017
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 11/2017
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 11/2017
1	Fenofibrate (CiL)FDA LinkGeneric 09/2017
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 09/2017
1	NucleophosminIBA 01/2017
1	Small Interfering RNA (siRNA)IBA 01/2017
1	Cyclin-Dependent Kinase Inhibitor p16IBA 05/2016
1	P-SelectinIBA 06/2015
1	Interleukin-4 (Interleukin 4)IBA 06/2015
1	Acetates (Acetic Acid Esters)FDA Link 05/2015
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 05/2015
1	Vitamin D FDA LinkGeneric 01/2015
1	thymoquinoneIBA 07/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2012
1	Matrix Metalloproteinases (MMPs)IBA 02/2012
1	Cell Cycle ProteinsIBA 10/2011
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 10/2011
1	Fluorescent Dyes (Fluorescent Probes)IBA 10/2011
1	Apoptosis Regulatory ProteinsIBA 10/2011
1	violaceinIBA 10/2011
1	Cytochromes c (Cytochrome c)IBA 10/2011
1	Caspase 9IBA 10/2011
1	Interferon gamma ReceptorIBA 03/2010

Therapy/Procedure

5	Therapeutics 01/2022 - 01/2012
2	Chemoprevention 01/2018 - 08/2009
1	Radiotherapy 01/2022
1	Drug Therapy (Chemotherapy) 01/2022